FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109) By linking statewide hospital discharge ...

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries—such as recommendations that they only be used in certain laparoscopic procedures, ...

Please provide your email address to receive an email when new articles are posted on . The FDA today issued a safety communication for patients and their health care providers that stresses the ...

On the heels of warnings from the U.S. Food and Drug Administration about the risks of using power morcellators in uterine surgery, the Judicial Panel on Multidistrict Litigation has been asked to ...

SILVER SPRING, Md., Feb. 25, 2020 /PRNewswire/ -- Today, we are taking several important steps to make the use of laparoscopic power morcellators (LPMs) safer in gynecologic surgeries, including ...

Howard Schwartz was left a widower after his wife developed cancer soon after her hysterectomy a year ago. (Russ DeSantis/For The Star Ledger) In The Star-Ledger's article ("FDA: Fibroid procedure can ...

If morcellation is under consideration, “it’s imperative to tell patients it could spread undetected cancer, worsen prognosis and that the device itself can cause injuries,” she said. Montalvo-Ariri, ...